Risk assessment model for venothromboembolism in post-hospitalized patients

International Angiology

Volumn 24, Issue 3, 2005, Pages 250-254

  Yale, Steven H ^a   Medlin, S C ^a   Liang, H ^a   Peters, T ^a   Glurich, I ^a   Mazza, J J ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Risk factors; Thromboembolism; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CLOMIFENE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; POTASSIUM CHLORIDE; TAMOXIFEN; THALIDOMIDE;

ANTICOAGULANT THERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; VALIDATION PROCESS; VENOUS THROMBOEMBOLISM;

HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT READMISSION; POSTOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 27744522881     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thrombembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 1991;17 Suppl 3:313-8.
2. International Consensus Statement (guidelines according to scientific evidence). Prevention of venous thromboembolism. Int Angiol 1997;16:3-38.
3. Russell MW, Taylor DC, Cummins G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002;8:S3-9.
4. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567-74.
5. Second Thromboembolic Risk Factors (THRIFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 1998;13:87-97.
6. Clagett GP, Anderson FA Jr, Geerts W, Heit JA, Knudson M, Lieberman JR et al. Prevention of venous thromboembolism. Chest 1998; 114(5 Suppl):531S-60S.
7. Motykie GD, Caprini JA, Arcelus JI, Zebala LP, Lee CE, Finke NM et al. Risk factor assessment in the management of patients with suspected deep vein thrombosis. Int Angiol 2000;19:47-51.
8. Storti S, Crucitti, Cina G. Risk factors and prevention of venous thromboembolism. Rays 1996;21:439-60.
9. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107(23 Suppl 1):I9-16.
10. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001;86:395-403.
11. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-8.
12. Eldor A. Applying risk assessment models in non-surgical patients: effective risk stratification. Blood Coagul Fibrinolysis 1999;10 Suppl 2:S91-7.
13. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999;78:285-91.
14. Wright G, Elliott K, Wilkie C, Cuschieri RJ, Bittiner B, Hughes KB. A prospective audit of hospital-acquired deep vein thrombosis and pulmonary embolism. Int J Clin Pract 1999;53:497-502.
15. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
16. DeWet CJ, Pearl RG. Postoperative thrombotic complications venous thromboembolism - deep-vein thrombosis and pulmonary embolism. Anesthesiol Clin North Am 1999;17:895-922.
17. Wille-Jorgensen P, Lausen I, Nannestad Jorgensen L. Is there a need for long-term thromboprophylaxis following general surgery? Haemostasis 1993;23 Suppl 1:10-4.
18. Gensini GF, Prisco D, Falciani M, Comeglio M, Colella A. Identification of candidates for prevention of venous thromboembolism. Semin Thromb Hemost 1997;23:55-67.
19. Shively BK. Deep venous thrombosis prophylaxis in patients with heart disease. Curr Cardiol Rep 2001;3:56-62.
20. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ et al. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005;93:76-9.
21. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000;83:657-60.